Tarsus Pharmaceuticals Ownership | Who Owns Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals Ownership Summary
Tarsus Pharmaceuticals is owned by 113.51% institutional investors, 8.77% insiders. Rtw investments, lp is the largest institutional shareholder, holding 9.67% of TARS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.98% of its assets in Tarsus Pharmaceuticals shares.
TARS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Tarsus Pharmaceuticals | 113.51% | 8.77% | -22.28% |
| Sector | Healthcare Stocks | 47.38% | 7.99% | 44.63% |
| Industry | Biotech Stocks | 45.43% | 7.81% | 46.75% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Rtw investments, lp | 3.41M | 9.67% | $92.75M |
| Blackrock | 3.27M | 9.25% | $88.79M |
| Paradigm biocapital advisors lp | 2.44M | 6.90% | $66.19M |
| Tang capital management | 2.25M | 6.39% | $61.29M |
| Cowen and company | 2.20M | 6.22% | $59.72M |
| Vanguard group | 1.99M | 5.64% | $54.08M |
| Morgan stanley | 1.88M | 5.34% | $51.23M |
| Frazier life sciences management | 1.59M | 4.50% | $43.15M |
| Jennison associates | 1.48M | 4.19% | $40.22M |
| Perceptive advisors | 1.30M | 3.67% | $35.24M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Tang capital management | 2.25M | 6.24% | $61.29M |
| Tfg asset management gp | 500.00K | 3.39% | $13.59M |
| Paradigm biocapital advisors lp | 2.44M | 2.53% | $66.19M |
| Frazier life sciences management | 1.59M | 2.02% | $43.15M |
| Ghost tree capital | 235.00K | 2.00% | $6.39M |
| Cowen and company | 2.20M | 1.64% | $59.72M |
| Tcg crossover management | 556.32K | 1.58% | $15.12M |
| Sands capital ventures | 170.00K | 1.55% | $4.62M |
| Rtw investments, lp | 3.41M | 1.44% | $92.75M |
| Integral health asset management | 400.00K | 1.03% | $10.87M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Assenagon asset management | 1.06M | 0.06% | 1.06M |
| Blackrock | 3.27M | 0.00% | 614.03K |
| Exoduspoint capital management, lp | 670.46K | 0.12% | 454.50K |
| Integral health asset management | 400.00K | 1.03% | 400.00K |
| Lord, abbett | 463.24K | 0.04% | 381.01K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Cormorant asset management, lp | 500.00K | 0.79% | -1.64M |
| Vivo capital | - | - | -565.55K |
| Morgan stanley | 1.88M | 0.00% | -514.23K |
| Healthcare of ontario pension plan trust fund | 389.60K | 0.03% | -508.40K |
| Paradigm biocapital advisors lp | 2.44M | 2.53% | -427.99K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Assenagon asset management | 1.06M | 0.06% | 1.06M | $28.90M |
| Integral health asset management | 400.00K | 1.03% | 400.00K | $10.87M |
| Caption management | 160.00K | 0.07% | 160.00K | $4.35M |
| Prudential financial | 79.52K | 0.00% | 79.52K | $2.16M |
| Silverarc capital management | 40.00K | 0.26% | 40.00K | $1.09M |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -5.00 |
| Riggs asset managment | -10.00 |
| Allworth financial lp | -21.00 |
| Innealta capital | -41.00 |
| Steward partners investment advisory | -59.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2024 | 153 | -6.71% | 40,069,329 | 2.31% | 113 | 0.92% | 94 | -9.62% | 43 | 34.38% |
| Mar 31, 2024 | 164 | 35.54% | 39,163,544 | 21.70% | 110 | 0.92% | 104 | 38.67% | 32 | 28.00% |
| Dec 31, 2023 | 121 | 11.01% | 32,180,491 | 8.01% | 109 | 1.16% | 75 | - | 25 | 92.31% |
| Sep 30, 2023 | 109 | 14.74% | 29,793,106 | 38.99% | 97 | 1.52% | 75 | 19.05% | 13 | -7.14% |
| Jun 30, 2023 | 95 | 25.00% | 21,435,682 | 6.87% | 79 | 1.42% | 63 | 70.27% | 14 | -30.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 1.14M | 2.98% | - |
| iShares Russell 2000 ETF | 945.73K | 2.49% | -2.13K |
| MEDICAL BioHealth EUR Acc | 628.24K | 1.65% | 354.25K |
| Vanguard Institutional Extnd Mkt Idx Tr | 529.32K | 1.39% | 53.80K |
| Invesco Small Cap Value A | 484.80K | 1.27% | - |
| PGIM Jennison Small Company A | 478.89K | 1.26% | 124.60K |
| Jennison SMid Cap Core Equity | 478.89K | 1.26% | 124.60K |
| Jennison Health Sciences Equity | 457.94K | 1.20% | 209.09K |
| PGIM Jennison Health Sciences Z | 457.94K | 1.20% | 209.09K |
| Artisan Non-U.S. Small-Mid Growth Comp | 457.19K | 1.20% | 64.35K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 12, 2024 | LINK WILLIAM J PHD | - | Sell | $133.21K |
| Aug 12, 2024 | LINK WILLIAM J PHD | - | Sell | $779.75K |
| Jun 18, 2024 | Farrow Jeffrey S | See Remarks | Sell | $286.92K |
| Mar 18, 2024 | Mottiwala Aziz | Chief Commercial Officer | Sell | $145.84K |
| Mar 18, 2024 | Wahl Bryan | General Counsel | Sell | $135.74K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | - |
| 2024 Q3 | - | 2 |
| 2024 Q2 | - | 1 |
| 2024 Q1 | - | 5 |
| 2023 Q4 | 1 | 11 |
TARS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools